Funded Tech Companies
Neurosterix
Headquartered in Geneva, Neurosterix has funding from Acorn Bioventures, Perceptive Xontogeny Venture Fund and Perceptive Advisors.
Company Overview
Company Name
Neurosterix
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
9 Chemin Des Mines
Geneva, 1202
Switzerland
Geneva, 1202
Switzerland
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators -- molecules that increase or decrease the activity of target receptors by binding outside of the "active site" where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix's novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/4/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Dyer
Company Investors
- Acorn Bioventures
- Perceptive Xontogeny Venture Fund
- Perceptive Advisors
Browse more funded tech companies:
Neurosonix | Neurotech Pharmaceuticals
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs